Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesGains from Investment SecuritiesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Cash from Investing Activities: 2020-2023

Historic Cash from Investing Activities for Pharming Group N.V (PHAR) over the last 2 years, with Jun 2023 value amounting to $87.3 million.

  • Pharming Group N.V's Cash from Investing Activities rose 1266.08% to $87.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was $87.4 million, marking a year-over-year increase of 682.38%. This contributed to the annual value of -$21,257 for FY2021, which is 99.86% up from last year.
  • As of Q2 2023, Pharming Group N.V's Cash from Investing Activities stood at $87.3 million, which was up 23,392.53% from -$375,000 recorded in Q4 2022.
  • In the past 5 years, Pharming Group N.V's Cash from Investing Activities registered a high of $87.3 million during Q2 2023, and its lowest value of -$7.7 million during Q2 2021.
  • In the last 3 years, Pharming Group N.V's Cash from Investing Activities had a median value of -$374,000 in 2022 and averaged $9.4 million.
  • As far as peak fluctuations go, Pharming Group N.V's Cash from Investing Activities plummeted by 14,480.90% in 2022, and later soared by 1,266.08% in 2023.
  • Over the past 4 years, Pharming Group N.V's Cash from Investing Activities (Quarterly) stood at -$4.2 million in 2020, then soared by 38.65% to -$2.6 million in 2021, then surged by 85.38% to -$375,000 in 2022, then skyrocketed by 1,266.08% to $87.3 million in 2023.
  • Its Cash from Investing Activities stands at $87.3 million for Q2 2023, versus -$375,000 for Q4 2022 and -$6.0 million for Q3 2022.